Work

Supplementary Figure 1 from Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: Pathways targeted by the Dana-Farber Targeted Therapy Collection and clinical development status

DOI: 10.1158/1078-0432.22458857.v1

Authors: Curtis R. Chong, Magda Bahcall, Marzia Capelletti, Takayuki Kosaka, Dalia Ercan, Taebo Sim, Lynette M. Sholl, Mizuki Nishino, Bruce E. Johnson, Nathanael S. Gray, Pasi A. Jänne

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361918490

Cites:

Cited by:

Related to: 10